Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
Understanding Patient Centricity, Progress Made, and Barriers Encountered: A Survey of Industry Professionals
Cactus Life Sciences conducted a survey of pharma/biotech and associated industry professionals to gather their...
Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR
The latest EU-MDR guidelines are a step in the right direction, moving from a focus...
Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)
Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs
As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
Reimagining the MSL-KOL Relationship
MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...